• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GLPG:BB

Snapshot for Galapagos NV (GLPG)

Open: - Day's Range: - Volume: 0
Previous Close: 15.9900 52wk Range: 13.4000 - 18.4200 1-Yr Rtn: -

Stock Chart for GLPG

No chart data available.
  • GLPG:BB 15.9900
  • 1M
  • 1Y
15.9900
Interactive GLPG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GLPG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. BEL20 -
Earnings Per Share (EUR) (ttm) 1.7800
Est. EPS (EUR) (12/2014) -0.9440
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 30.28
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GLPG

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GLPG

Galapagos NV is a drug discovery company focused on the identification of disease modifying drug targets. The Company specializes in osteoporosis, rheumatoid arthritis, osteoarthritis and Alzheimer's disease.

Onno Van De StolpeCEO/Executive DirectorLaure VerhaegenInterim CFO/VP:Finance
Piet WigerinckChief Scientific OfficerDavid SmithCEO:Service Division
More Company Profile & Key Executives for GLPG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil